Last Updated:
Name Designation Appointment Date Status
Vemula Rajinikanth

Appointed as Director since October 2024

Director 03-Oct-2024 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Suman Neelam

Appointed as Director since October 2024

Director 03-Oct-2024 Current

People Timeline

Explore the timeline of key personnel in Medclone Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address H.No.2-4-1049/104, Flat No. 104, First Floor, Sai Ram Avenue, Road No.2, New Samathapuri Colony, Nagole, Hyderabad Telangana, 500035, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 500035
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Medclone Pharmaceuticals Private Limited?
You can contact Medclone Pharmaceuticals Private Limited through their registered address at H.No.2-4-1049/104, Flat No. 104, First Floor, Sai Ram Avenue, Road No.2, New Samathapuri Colony, Nagole, Hyderabad Telangana, 500035, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Medclone Pharmaceuticals Private Limited?
The current directors of Medclone Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • Vemula Rajinikanth
  • Suman Neelam
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available